Skip Navigation
CNBC
Markets
  • Pre-Markets
  • U.S. Markets
  • Currencies
  • Prediction Markets
  • Cryptocurrency
  • Futures & Commodities
  • Bonds
  • Funds & ETFs
Business
  • Economy
  • Finance
  • Health & Science
  • Media
  • Real Estate
  • Energy
  • Climate
  • Transportation
  • Investigations
  • Industrials
  • Retail
  • Wealth
  • Sports
  • Life
  • Small Business
Investing
  • Personal Finance
  • Fintech
  • Financial Advisors
  • Options Action
  • ETF Street
  • Buffett Archive
  • Earnings
  • Trader Talk
Tech
  • Cybersecurity
  • AI
  • Enterprise
  • Internet
  • Media
  • Mobile
  • Social Media
  • CNBC Disruptor 50
  • Tech Guide
Politics
  • White House
  • Policy
  • Defense
  • Congress
  • Expanding Opportunity
Video
  • Latest Video
  • Full Episodes
  • Livestream
  • Live Audio
  • Live TV Schedule
  • CNBC Podcasts
  • CEO Interviews
  • CNBC Documentaries
  • Digital Originals
Watchlist
Investing Club
  • Trust Portfolio
  • Analysis
  • Trade Alerts
  • Meeting Videos
  • Homestretch
  • Jim's Columns
  • Education
  • Subscribe
Join IC
PRO
  • Pro News
  • Josh Brown
  • Mike Santoli
  • Calls of the Day
  • My Portfolio
  • Livestream
  • Full Episodes
  • Stock Screener
  • Market Forecast
  • Options Investing
  • Chart Investing
  • Subscribe
Join Pro
Livestream
  • Make It
  • select
  • USA
  • INTL
  • Livestream
  • Livestream
Watchlist
SIGN IN
Create free account
Markets
Business
Investing
Tech
Politics
Video
Watchlist
Investing Club
Join IC
PRO
Join Pro
Livestream

background of header
foreground of header
  • Newsletter
Healthy Returns: Botox, Trulicity among 15 drugs added to Medicare price negotiations
Healthy Returns: Botox, Trulicity among 15 drugs added to Medicare price negotiations
Wed, Jan 28th 2026
Healthy Returns: Structure Therapeutics CEO on obesity pills, future of GLP-1s
Healthy Returns: Structure Therapeutics CEO on obesity pills, future of GLP-1s
Wed, Jan 21st 2026
Healthy Returns: Novo CEO on GLP-1 pricing, and more insights from the JPM conference
Healthy Returns: Novo CEO on GLP-1 pricing, and more insights from the JPM conference
Fri, Jan 16th 2026
Healthy Returns: What to expect from pharma at the JPM conference
Healthy Returns: What to expect from pharma at the JPM conference
Fri, Jan 9th 2026
Healthy Returns: 2026 will be the year of obesity pills
Healthy Returns: 2026 will be the year of obesity pills
Tue, Dec 16th 2025
Healthy Returns: FDA may add its strongest safety warning to Covid vaccines
Healthy Returns: FDA may add its strongest safety warning to Covid vaccines
Fri, Dec 12th 2025
Healthy Returns: Novo Nordisk boosts the case for its obesity pill with new data
Healthy Returns: Novo Nordisk boosts the case for its obesity pill with new data
Wed, Nov 12th 2025
FOLLOW
Twitter IconA Twitter icon
About

Top health care investors, CEOs and technologists explore the innovations that will drive better outcomes, financially and clinically. For more exclusive insights from our reporters and speakers, sign up for our Healthy Returns newsletter to get the latest delivered straight to your inbox weekly.

More in Healthy Returns

Healthy Returns: What to know about Pfizer, Novo Nordisk’s bidding war over obesity biotech Metsera
Annika Kim Constantino|Bertha CoombsWed, Nov 5th 2025
Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings
Annika Kim ConstantinoTue, Oct 28th 2025
Healthy Returns: A key step forward for Novo Nordisk's GLP-1 pill
Annika Kim Constantino|Bertha CoombsTue, Oct 21st 2025
Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers
Annika Kim Constantino|Bertha CoombsTue, Oct 7th 2025
Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug
Annika Kim Constantino|Bertha CoombsTue, Sep 30th 2025
Healthy Returns: What to know about RFK Jr.'s five new vaccine panel members
Annika Kim Constantino|Ashley CapootWed, Sep 17th 2025
Healthy Returns: New FDA rules affect copycat GLP-1s, and Apple adds health tools to latest Watch
Annika Kim Constantino|Ashley CapootWed, Sep 10th 2025
Healthy Returns: Novo Nordisk’s head of research and development previews the first obesity pill
Annika Kim Constantino|Ashley CapootWed, Sep 3rd 2025
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
Annika Kim Constantino|Bertha CoombsTue, Aug 26th 2025
Healthy Returns: New study casts doubts on RFK Jr.'s reasons for gutting key vaccine panel
Annika Kim Constantino|Bertha CoombsTue, Aug 19th 2025
Healthy Returns: FDA launches program to streamline creation of new U.S. drug manufacturing sites 
Annika Kim Constantino|Ashley CapootWed, Aug 13th 2025
Healthy Returns: Medicare, Medicaid to reportedly pilot covering obesity drugs in win for drugmakers
Annika Kim Constantino|Ashley CapootTue, Aug 5th 2025
Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressure
Annika Kim Constantino|Ashley CapootWed, Jul 30th 2025
Healthy Returns: Researchers move closer to a universal cancer vaccine
Annika Kim Constantino|Ashley CapootWed, Jul 23rd 2025
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Annika Kim Constantino|Ashley CapootWed, Jul 16th 2025
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
Annika Kim Constantino|Ashley CapootTue, Jul 8th 2025
Healthy Returns: What to know about a CDC vaccine panel's votes against a preservative in flu shots
Annika Kim Constantino|Ashley CapootTue, Jul 1st 2025
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Annika Kim Constantino|Ashley CapootWed, Jun 25th 2025
Healthy Returns: What to know about the FDA’s plan to speed up some drug reviews
Annika Kim Constantino|Ashley CapootFri, Jun 20th 2025
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
Annika Kim Constantino|Ashley CapootWed, Jun 11th 2025
Healthy Returns: AstraZeneca, Pfizer, Gilead, others release promising cancer drug data at ASCO
Annika Kim Constantino|Ashley CapootWed, Jun 4th 2025
Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access
Annika Kim Constantino|Ashley CapootWed, May 28th 2025
Healthy Returns: Novavax scores narrower Covid vaccine approval after delay
Annika Kim Constantino|Ashley CapootTue, May 20th 2025
Healthy Returns: Trump provides a glimpse of the third round of Medicare drug price negotiations
Annika Kim Constantino|Ashley CapootWed, May 14th 2025
CNBC logo
  • Subscribe to CNBC PRO
  • Subscribe to Investing Club
  • Licensing & Reprints
  • CNBC Councils
  • Select Personal Finance
  • Join the CNBC Panel
  • Closed Captioning
  • Digital Products
  • News Releases
  • Internships
  • Corrections
  • About CNBC
  • Site Map
  • Podcasts
  • Careers
  • Help
  • Contact
  • News Tips

    Got a confidential news tip? We want to hear from you.

    Get In Touch
  • CNBC Newsletters

    Sign up for free newsletters and get more CNBC delivered to your inbox

    Sign Up Now

    Get this delivered to your inbox, and more info about our products and services.

  • Advertise With Us

    Please Contact Us
  • Ad Choices
  • Privacy Policy
  • California Consumer Privacy Act (CCPA) Opt-Out IconYour Privacy Choices
  • CA Notice
  • Terms of Service

© 2026 Versant Media, LLC. All Rights Reserved. A Versant Media Company.

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided byReuters logo